Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure

Lignende værker

• Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure
  af: Prébet, Thomas, et al.
  Udgivet: (2011)
• Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure
  af: Prébet, Thomas, et al.
  Udgivet: (2013)
• A randomized phase II trial of azacitidine +/− epoetin-β in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents
  af: Thépot, Sylvain, et al.
  Udgivet: (2016)
• Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system
  af: Prebet, Thomas, et al.
  Udgivet: (2016)
• Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
  af: R Edlin, et al.
  Udgivet: (2010-05-01)